Page 7 - 2019_12-Haematologica-web

Acute Myeloid Leukemia
2400 Clonal hematopoiesis and risk of acute myeloid leukemia Andrew L. Young et al.
2418 FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways
Min Wu et al.
Chronic Lymphocytic Leukemia
2429 Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells Carmela Ciardullo et al.
2443 Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells Miroslav Boudny et al.
Plasma Cell Disorders
2456 Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples Florentin Späth et al.
2465 Functional interplay between NF-kB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma Laura Mazzera et al.
2493 Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence Annabelle Dupont et al.
Hemostasis
2501 Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
Khalil El Karou et al.
Coagulation & its Disorders
2512 Incidence and features of thrombosis in children with inherited antithrombin deficiency Belén de la Morena-Barrio et al.
2519 Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for b2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
Marisa Benagiano et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/104/12.toc
e543 Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease Barbara Cappelli et al.
http://www.haematologica.org/content/104/12/e543
e547 The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile? Margot F. van Spronsen et al.
http://www.haematologica.org/content/104/12/e547
e551 Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis
Simon T. Durrant et al.
http://www.haematologica.org/content/104/12/e551
e555 Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial
Rohtesh S. Mehta et al.
http://www.haematologica.org/content/104/12/e555
Platelet Biology & its Disorders
2482 Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release Susheel N. Chaurasia et al.
haematologica Journal of the Ferrata Storti Foundation
Haematologica 2019; vol. 104 no. 12 - December 2019 http://www.haematologica.org/